2021 Meningioma Day
May 10, 2021
2021 Meningioma Day
Current Management Strategies and Future Directions
May 15, 2021, 8:20 a.m. – 4:30 p.m. EST
The Society for Neuro-Oncology and the International Consortium on Meningiomas, in partnership with the National Cancer Institute and the Neurosurgical Atlas, are pleased to announce a special one-day conference, 2021 Meningioma Day, Current management strategies and future directions, on May 15, 2021, from 8:20 a.m.-4:30 p.m. EST.
Overview
This education day will focus on meningiomas: a look at current management strategies and a preview of what the future might hold. The talks will center around surgery & adjuvant therapy of challenging meningiomas, clinical updates in meningioma management and trial design, as well as basic and translational advances in the study of meningioma biology. Each section will conclude with an interactive discussion. Meningioma Day will be open to all. We hope to attract attendees from diverse fields with unique experiences and expertise including clinicians, investigators, scientists, allied health, community practitioners, students, and trainees.
Learning objectives
- Review current standards of care and surgical decision making for meningiomas
- Overview of advances in meningioma biology and research
- Provide in-depth review of existing and future clinical trials in meningiomas
Chairs
Ian Dunn, University of Oklahoma
Gelareh Zadeh, University of Toronto
Faculty
Aaron Cohen-Gadol, Indiana University School of Medicine
Amir Zamanipoor, Leiden University Medical Center
Andrew Morokoff, Royal Melbourne
Christopher P Millward, University of Liverpool
Daniel Prevedello, The Ohio State University
David Raleigh, University of California San Francisco
David Reardon, Dana Farber Cancer Institute
Erik Sulman, NYU Langone
Felix Behling, University of Tuebingen
Felix Sahm, German Cancer Research Center
Ghazaleh Tabatabai, University Hospital Tübingen
Isabelle Germano, Mount Sinai
Jacques J. Morcos, University of Miami
Jill S. Barnholtz-Sloan, Case Comprehensive Cancer Center
Kate Drummond, Royal Melbourne
Kenneth Aldape, National Institute of Health
Mark Gilbert, National Institute of Health
Michael Jenkinson, University of Liverpool
Michael McDermott, Baptist Health
Priscilla Brastianos, Massachusetts General
Roland Goldbrunner, University of Cologne
Serge Makarenko, Diamond Health Care Centre
Stephen Yip, The University of British Columbia
Terri Armstrong, National Institute of Health
Wenya Linda Bi, Brigham and Women’s
William Couldwell, University of Utah